3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase EARLY_PHASE1
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
2
Thoracic
1
Other solid neoplasm
1
Conditions
Peritoneal Neoplasms
9
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Ovarian Epithelial
3
Stomach Neoplasms
2
Mesothelioma
2
Adrenocortical Carcinoma
2
Pseudomyxoma Peritonei
1
Neoplasms
1
Neoplasm Metastasis
1
Hyperthermia
1
Gastrointestinal Neoplasms
1
Gastric Adenocarcinoma
1
Colonic Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Brenner Tumor
1
Appendiceal Neoplasms
1
Abdominal Neoplasms
1
Interventions
Oxaliplatin
166
Capecitabine
112
Fluorouracil
95
Docetaxel
85
Cisplatin
84
S 1 (combination)
83
Leucovorin
64
Paclitaxel
58
Irinotecan
56
pembrolizumab
36
sintilimab
34
Trastuzumab
34
apatinib
30
Bevacizumab
21
Surgical Procedures, Operative
19
Radiotherapy
19
titanium silicide
17
camrelizumab
17
Nivolumab
17
Ramucirumab
16
Drug Therapy
15
Hyperthermic Intraperitoneal Chemotherapy
14
Folfox protocol
14
Epirubicin
14
tislelizumab
13
Neoadjuvant Therapy
12
Cetuximab
12
XELOX
10
Tegafur
10
Carboplatin
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Stomach Neoplasms
×
Cytoreduction Surgical Procedures
×
Clear all
NCT03150628
2019-04-17
CISCA
UMC Utrecht
Phase 2
Terminated
3 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled